A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Condition: Crohn's Disease Interventions: Drug: Vedolizumab; Drug: Adalimumab; Drug: Ustekinumab Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials